Geneva Capital Management’s STAAR Surgical STAA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-662,825
| Closed | -$16.1M | – | 130 |
|
2024
Q4 | $16.1M | Sell |
662,825
-32,590
| -5% | -$792K | 0.28% | 84 |
|
2024
Q3 | $25.8M | Buy |
695,415
+2,241
| +0.3% | +$83.3K | 0.43% | 73 |
|
2024
Q2 | $33M | Sell |
693,174
-18,020
| -3% | -$858K | 0.6% | 53 |
|
2024
Q1 | $27.2M | Sell |
711,194
-206,962
| -23% | -$7.92M | 0.48% | 69 |
|
2023
Q4 | $28.7M | Sell |
918,156
-35,822
| -4% | -$1.12M | 0.54% | 64 |
|
2023
Q3 | $38.3M | Buy |
953,978
+2,949
| +0.3% | +$118K | 0.81% | 45 |
|
2023
Q2 | $50M | Sell |
951,029
-6,828
| -0.7% | -$359K | 0.99% | 38 |
|
2023
Q1 | $61.3M | Buy |
957,857
+17,400
| +2% | +$1.11M | 1.25% | 29 |
|
2022
Q4 | $45.6M | Sell |
940,457
-6,669
| -0.7% | -$324K | 1.03% | 37 |
|
2022
Q3 | $66.8M | Buy |
947,126
+38,327
| +4% | +$2.7M | 1.54% | 17 |
|
2022
Q2 | $64.5M | Sell |
908,799
-1,078
| -0.1% | -$76.5K | 1.48% | 19 |
|
2022
Q1 | $72.7M | Buy |
909,877
+158,452
| +21% | +$12.7M | 1.4% | 24 |
|
2021
Q4 | $68.6M | Buy |
751,425
+55,405
| +8% | +$5.06M | 1.11% | 33 |
|
2021
Q3 | $89.5M | Sell |
696,020
-125,697
| -15% | -$16.2M | 1.52% | 19 |
|
2021
Q2 | $125M | Sell |
821,717
-113,249
| -12% | -$17.3M | 2.04% | 6 |
|
2021
Q1 | $98.6M | Sell |
934,966
-348,267
| -27% | -$36.7M | 1.68% | 15 |
|
2020
Q4 | $102M | Sell |
1,283,233
-66,878
| -5% | -$5.3M | 1.72% | 14 |
|
2020
Q3 | $76.4M | Buy |
1,350,111
+31,581
| +2% | +$1.79M | 1.58% | 15 |
|
2020
Q2 | $81.1M | Buy |
1,318,530
+36,728
| +3% | +$2.26M | 1.76% | 11 |
|
2020
Q1 | $41.4M | Buy |
+1,281,802
| New | +$41.4M | 1.18% | 29 |
|